23-EPI-26-Deoxyactein(27-Deoxyactein)
APC-872
23-EPI-26-Deoxyactein(27-Deoxyactein)
Cat. No.
APC-872
CAS No.
501938-01-8
MF
C37H56O10
MW
660.845
23-EPI-26-Deoxyactein(27-Deoxyactein) is a constituent isolated from Cimicifuga racemosa.
Technical Service Need help? Our team of experienced experts is here for you with full support.
86-28-85159085
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
CAS No.
501938-01-8
MF
C37H56O10
MW
660.845
Specification
98%
Research Area
Anti-obesity and anti-cancer
Description
23-EPI-26-Deoxyactein(27-Deoxyactein) is a constituent isolated from Cimicifuga racemosa. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Documents
Certificate of Analysis (COA), Specification Sheet, HPLC, 1HNMR, 13CNMR, IR, MS, Safety Data Sheet (SDS/MSDS) etc.
Storage and Shipping
Store under frozen or refrigerated conditions, keep away from strong light and heat.
References
[1]. Jingjing Yuan, et al. Effects of 23-epi-26-deoxyactein on adipogenesis in 3T3-L1 preadipocytes and diet-induced obesity in C57BL/6 mice. Phytomedicine. 2020 Jun 5;76:153264.
[2]. Kwang Sik Suh, et al. Deoxyactein protects pancreatic β-cells against methylglyoxal-induced oxidative cell damage by the upregulation of mitochondrial biogenesis. Int J Mol Med. 2017 Aug;40(2):539-548.
[3]. Einbond, L.S., et al. Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells. Breast Cancer Res. Treat. 83, 221–231. Breast Cancer Res Treat. 2004 Feb;83(3):221-31.
[4]. Eun Mi Choi, et al. Deoxyactein Isolated from Cimicifuga racemosa protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity. J Appl Toxicol. 2013 Jun;33(6):488-94.
[2]. Kwang Sik Suh, et al. Deoxyactein protects pancreatic β-cells against methylglyoxal-induced oxidative cell damage by the upregulation of mitochondrial biogenesis. Int J Mol Med. 2017 Aug;40(2):539-548.
[3]. Einbond, L.S., et al. Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells. Breast Cancer Res. Treat. 83, 221–231. Breast Cancer Res Treat. 2004 Feb;83(3):221-31.
[4]. Eun Mi Choi, et al. Deoxyactein Isolated from Cimicifuga racemosa protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity. J Appl Toxicol. 2013 Jun;33(6):488-94.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
APC-1828
Eritadenine
CAS No.: 23918-98-1
MF: C9H11N5O4
APC-1827
Isobutyrylshikonin
CAS No.:52438-12-7
MF:C20H22O6
APC-1823
SO1861 (C28 sugar-chain positional isomer)
CAS No.:N/A
MF:C83H129O46
APC-1822
Bromocriptine mesylate
CAS No.:22260-51-1
MF:C32H40BrN5O5.CH4O3S
APC-1821
Cephaeline hydrochloride
CAS No.:3738-70-3
MF:C28H38N2O4.ClH
APC-1820
8-Feruloylharpagide
CAS No.:221003-20-9
MF:C25H32O13
APC-1819
6''-O-(p-coumaroyl)procumbide
CAS No.:87686-76-8
MF:C24H28O12
APC-1818
6′′-O-(p-Coumaroyl)harpagide
CAS No.:133561-42-9
MF:C24H30O12
APC-1817
Falcarinol
CAS No.:21852-80-2
MF:C17H24O
APC-1816
Dehydrotomatine
CAS No.:157604-98-3
MF:C50H81NO21
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
